ConductScience.org, home

Paper29439820

Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.

Antonarakis ES and 11 others. Eur Urol, 2018. Cited by 156 papers, by iCite.

Cite this record

ConductScience Library. Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide. Papers, record 29439820. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29439820

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.
PubMed
Journal
Eur Urol
PubMed
Year
2018
PubMed
Publication types
Comparative Study, Journal Article, Observational Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
156
iCite
Relative citation ratio, by iCite
4.85
iCite
Revised in PubMed
2022-03-31
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Antonarakis ESEmmanuel S
2Lu CChangxue
3Luber BBrandon
4Liang CChao
5Wang HHao
6Chen YYan
7Silberstein JLJohn L
8Piana DDanilo
9Lai ZZhao
10Chen YYidong
11Isaacs WBWilliam B
12Luo JJun

Source PubMed

Download CSV of authors

Topics30

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Androgen AntagonistsMajor topic
AndrostenesMajor topic
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Biomarkers, TumorMajor topic
DNA Repair EnzymesMajor topic
Germ-Line MutationMajor topic
PhenylthiohydantoinMajor topic
Prostatic Neoplasms, Castration-ResistantMajor topic
Aged
Antigens, Neoplasm
Ataxia Telangiectasia Mutated Proteins
BRCA1 Protein
BRCA2 Protein
Benzamides
Clinical Decision-Making
DNA Mutational Analysis
GPI-Linked Proteins
Genetic Predisposition to Disease
Humans
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Proteins
Nitriles
Phenotype
Precision Medicine
Progression-Free Survival
Prospective Studies
Time Factors
Treatment Outcome

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA006973NCI NIH HHSUnited StatesP30CA006973PubMed and NIHNIH RePORTER
P50 CA058236NCI NIH HHSUnited StatesP50CA058236PubMed and NIHNIH RePORTER
R01 CA185297NCI NIH HHSUnited StatesR01CA185297PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in30360342Re: Germline DNA-Repair Gene Mutations and Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer Receiving First-Line Abiraterone and Enzalutamide.https://conductscience.org/library/papers/30360342

Source PubMed

Download CSV of comments and corrections

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128259476Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer.Eur Urol2017https://conductscience.org/library/papers/28259476PubMed
227433846Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.N Engl J Med2016https://conductscience.org/library/papers/27433846PubMed
327989354Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.Eur Urol2017https://conductscience.org/library/papers/27989354PubMed
425454609Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer.Eur Urol2015https://conductscience.org/library/papers/25454609PubMed
518309951Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.J Clin Oncol2008https://conductscience.org/library/papers/18309951PubMed
628843286Integrative Clinical Genomics of Advanced Prostate Cancer.Cell2015https://conductscience.org/library/papers/28843286PubMed
724027196Androgen receptor signaling regulates DNA repair in prostate cancers.Cancer Discov2013https://conductscience.org/library/papers/24027196PubMed
826775620BRCAness revisited.Nat Rev Cancer2016https://conductscience.org/library/papers/26775620PubMed
928608931The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer.Cancer2017https://conductscience.org/library/papers/28608931PubMed
1019097774New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).Eur J Cancer2009https://conductscience.org/library/papers/19097774PubMed
1126582918ClinVar: public archive of interpretations of clinically relevant variants.Nucleic Acids Res2016https://conductscience.org/library/papers/26582918PubMed
1225255306Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer.Nat Commun2014https://conductscience.org/library/papers/25255306PubMed
1326746459Familial Risk and Heritability of Cancer Among Twins in Nordic Countries.JAMA2016https://conductscience.org/library/papers/26746459PubMed
1428573914Treatment strategies for DNA repair-deficient prostate cancer.Expert Rev Clin Pharmacol2017https://conductscience.org/library/papers/28573914PubMed
1526510020DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.N Engl J Med2015https://conductscience.org/library/papers/26510020PubMed
1628314609Germline DNA Repair Mutations and Response to Hormonal Therapy in Advanced Prostate Cancer.Eur Urol2017https://conductscience.org/library/papers/28314609PubMed
1724027197A hormone-DNA repair circuit governs the response to genotoxic insult.Cancer Discov2013https://conductscience.org/library/papers/24027197PubMed

Download CSV of references

Cited by98

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 156 citations.

PMIDTitleJournalYearIn PapersSource
42832307Non-conventional histologies of prostate cancer: from morphology to biology-driven precision oncology.Oncologist2026https://conductscience.org/library/papers/42832307PubMed
42754663CRISPR/Cas9 screening revealed BIRC6-AS1/BIRC6 mediates abiraterone resistance via NHEJ pathway-dependent A20 degradation in prostate cancer.Oncogene2026https://conductscience.org/library/papers/42754663PubMed
42667419Expected costs and benefits of genetic counselling and germline genetic testing in metastatic prostate cancer.Hum Genet2026https://conductscience.org/library/papers/42667419PubMed
42588618Real-World Outcomes of DNA Damage Repair Altered Metastatic Castration-Resistant Prostate Cancer: Insights from FFPE-Based Genomic Profiling.Cancers (Basel)2026https://conductscience.org/library/papers/42588618PubMed
42115448Olaparib combined with abiraterone in HRR-mutated metastatic hormone-sensitive prostate cancer: a single-arm phase II trial.World J Urol2026https://conductscience.org/library/papers/42115448PubMed
42092965PARG inhibition in ATM-deficient prostate cancer: from mechanistic discovery to therapeutic potential.J Transl Med2026https://conductscience.org/library/papers/42092965PubMed
40971752Prognostic Significance of RB1 Alterations on Outcomes in Metastatic Prostate Cancer.JCO Precis Oncol2025https://conductscience.org/library/papers/40971752PubMed
40891997Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer.BJU Int2025https://conductscience.org/library/papers/40891997PubMed
40744833Prostate cancer germline variants with therapeutic implications.Trends Mol Med2026https://conductscience.org/library/papers/40744833PubMed
40736216
Efficacy and safety of first-line treatments for metastatic castration-resistant prostate cancer based on phase II and III randomized controlled trials: A PROSTA-MAP systematic review and network meta-analysis.
Chin Med J (Engl)2026https://conductscience.org/library/papers/40736216PubMed
40002869The Tight Relationship Between the Tumoral Microenvironment and Radium-223.Biomedicines2025https://conductscience.org/library/papers/40002869PubMed
40001885Early Detection of the Pathogenetic Variants of Homologous Recombination Repair Genes in Prostate Cancer: Critical Analysis and Experimental Design.Biology (Basel)2025https://conductscience.org/library/papers/40001885PubMed
39917165Interactions between key genes and pathways in prostate cancer progression and therapy resistance.Front Oncol2025https://conductscience.org/library/papers/39917165PubMed
39516637Germline sequencing in men with metastatic castration-resistant prostate cancer from the BARCODE2 study reveals a wide range of pathogenic variants in DNA repair genes.BJC Rep2024https://conductscience.org/library/papers/39516637PubMed
39455978Clinical relevance of protein-truncating variants of germline DNA repair genes in prostate cancer.BMC Cancer2024https://conductscience.org/library/papers/39455978PubMed
39450704Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate Cancer.Clin Cancer Res2025https://conductscience.org/library/papers/39450704PubMed
39333696Therapeutic implications of homologous repair deficiency testing in patients with prostate cancer (Part 2 of 2).Prostate Cancer Prostatic Dis2025https://conductscience.org/library/papers/39333696PubMed
39301117Utility of pembrolizumab for metastatic castrate resistant prostate cancer with MMR deficiency.Urol Case Rep2024https://conductscience.org/library/papers/39301117PubMed
39257456Homologous Recombination Repair Testing Patterns and Outcomes in mCRPC by Alteration Status and Race.Clinicoecon Outcomes Res2024https://conductscience.org/library/papers/39257456PubMed
38885246TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutations.Oncologist2024https://conductscience.org/library/papers/38885246PubMed

See all 98 cited byDownload CSV of cited by

Genes54

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABRAXAS184142PubTator's text mininghttps://conductscience.org/library/genes/84142NCBI Gene
ABRAXAS223172PubTator's text mininghttps://conductscience.org/library/genes/23172NCBI Gene
AR367PubTator's text mininghttps://conductscience.org/library/genes/367NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
ATR545PubTator's text mininghttps://conductscience.org/library/genes/545NCBI Gene
BAP18314PubTator's text mininghttps://conductscience.org/library/genes/8314NCBI Gene
BARD1580PubTator's text mininghttps://conductscience.org/library/genes/580NCBI Gene
BLM641PubTator's text mininghttps://conductscience.org/library/genes/641NCBI Gene
BRAP8315PubTator's text mininghttps://conductscience.org/library/genes/8315NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
BRIP183990PubTator's text mininghttps://conductscience.org/library/genes/83990NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene
CDK1251755PubTator's text mininghttps://conductscience.org/library/genes/51755NCBI Gene
CENPQ55166PubTator's text mininghttps://conductscience.org/library/genes/55166NCBI Gene
CHEK11111PubTator's text mininghttps://conductscience.org/library/genes/1111NCBI Gene
CHEK211200PubTator's text mininghttps://conductscience.org/library/genes/11200NCBI Gene
EPCAM4072PubTator's text mininghttps://conductscience.org/library/genes/4072NCBI Gene
ERCC12067PubTator's text mininghttps://conductscience.org/library/genes/2067NCBI Gene
ERCC22068PubTator's text mininghttps://conductscience.org/library/genes/2068NCBI Gene

See all 54 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29439820

GET https://conductscience.org/api/papers/v1/29439820/cited_by?page=2